Novel mutation and severe respiratory failure in congenital disorders of glycosylation Type Ix

Congenital glycosylation disorders (CDG) are a group of rare hereditary metabolic diseases that result from abnormal protein and lipid glycosylation. Virtually all organ systems can be affected, and neurological involvement is particularly severe and disabling. More than 100 CDG types have be...

Full description

Saved in:
Bibliographic Details
Main Authors: Betül Kılıç, Nejmiye Akkuş
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2020-02-01
Series:The Turkish Journal of Pediatrics
Subjects:
Online Access:https://turkjpediatr.org/article/view/418
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850041921778483200
author Betül Kılıç
Nejmiye Akkuş
author_facet Betül Kılıç
Nejmiye Akkuş
author_sort Betül Kılıç
collection DOAJ
description Congenital glycosylation disorders (CDG) are a group of rare hereditary metabolic diseases that result from abnormal protein and lipid glycosylation. Virtually all organ systems can be affected, and neurological involvement is particularly severe and disabling. More than 100 CDG types have been reported to date and those numbers are rapidly increasing. Each type is very rare, and the clinical characteristics of each subtype are difficult to determine. There are large numbers of biochemically unresolved cases defined as CDGIx. In this report, we present a 5-year-old boy who had dysmorphic features, hypotonia, developmental and mental delay, epileptic spasms, recurrent apnea and respiratory failure that led to the diagnosis of an unreported mutation of a rare form of CDG-Ix. This mutation in the STT3B gene affects the catalytic subunit of the oligosaccharyltransferase and the recipient substrate properties, which in part have the same functions in N-glycosylation. A novel homozygous mutation in the STT3B presence of c.38C > G that encodes p.S13W (p.Ser13Trp) was detected with next generation sequencing. The CDG clinical spectrum can be unusual, ranging from dysfunction of certain organs to severe multiple system disorders. Respiratory failure has rarely been reported in these cases. Increased types and numbers of patients constitute symptom variety. The identification of new genes and genotype-phenotype relationships may expand the family of CDG.
format Article
id doaj-art-5f2fcabcfb7c4b089e01bab49f0f4e40
institution DOAJ
issn 0041-4301
2791-6421
language English
publishDate 2020-02-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-5f2fcabcfb7c4b089e01bab49f0f4e402025-08-20T02:55:41ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212020-02-0162110.24953/turkjped.2020.01.016Novel mutation and severe respiratory failure in congenital disorders of glycosylation Type IxBetül Kılıç0Nejmiye Akkuş1Departments of Pediatric Neurology, University of Health Sciences, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey.Departments of Medical Genetics, University of Health Sciences, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey. Congenital glycosylation disorders (CDG) are a group of rare hereditary metabolic diseases that result from abnormal protein and lipid glycosylation. Virtually all organ systems can be affected, and neurological involvement is particularly severe and disabling. More than 100 CDG types have been reported to date and those numbers are rapidly increasing. Each type is very rare, and the clinical characteristics of each subtype are difficult to determine. There are large numbers of biochemically unresolved cases defined as CDGIx. In this report, we present a 5-year-old boy who had dysmorphic features, hypotonia, developmental and mental delay, epileptic spasms, recurrent apnea and respiratory failure that led to the diagnosis of an unreported mutation of a rare form of CDG-Ix. This mutation in the STT3B gene affects the catalytic subunit of the oligosaccharyltransferase and the recipient substrate properties, which in part have the same functions in N-glycosylation. A novel homozygous mutation in the STT3B presence of c.38C > G that encodes p.S13W (p.Ser13Trp) was detected with next generation sequencing. The CDG clinical spectrum can be unusual, ranging from dysfunction of certain organs to severe multiple system disorders. Respiratory failure has rarely been reported in these cases. Increased types and numbers of patients constitute symptom variety. The identification of new genes and genotype-phenotype relationships may expand the family of CDG. https://turkjpediatr.org/article/view/418STT3Bcongenital disorders of glycosylation Type Ixnovel mutationrespiratory failure
spellingShingle Betül Kılıç
Nejmiye Akkuş
Novel mutation and severe respiratory failure in congenital disorders of glycosylation Type Ix
The Turkish Journal of Pediatrics
STT3B
congenital disorders of glycosylation Type Ix
novel mutation
respiratory failure
title Novel mutation and severe respiratory failure in congenital disorders of glycosylation Type Ix
title_full Novel mutation and severe respiratory failure in congenital disorders of glycosylation Type Ix
title_fullStr Novel mutation and severe respiratory failure in congenital disorders of glycosylation Type Ix
title_full_unstemmed Novel mutation and severe respiratory failure in congenital disorders of glycosylation Type Ix
title_short Novel mutation and severe respiratory failure in congenital disorders of glycosylation Type Ix
title_sort novel mutation and severe respiratory failure in congenital disorders of glycosylation type ix
topic STT3B
congenital disorders of glycosylation Type Ix
novel mutation
respiratory failure
url https://turkjpediatr.org/article/view/418
work_keys_str_mv AT betulkılıc novelmutationandsevererespiratoryfailureincongenitaldisordersofglycosylationtypeix
AT nejmiyeakkus novelmutationandsevererespiratoryfailureincongenitaldisordersofglycosylationtypeix